Our review explored various aspects of lung adenocarcinoma, including the overexpression of VEGF and its corresponding receptor (VEGFR), the intricate signaling pathways involved in lung cancer progression, and nanomedicine applications to it. This evidence concerns the gene VEGFA and lung adenocarcinoma.